Milestone Pharmaceuticals MIST Q1 2025 earnings
Reported May 14, 2025 · Before market open
EPS estimate-$0.19
Next report
Aug 12, 2026 (in a month)Revenue estimate$1.1M
EPS estimate-$0.18
Versus estimates
Ask the moment Milestone Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Milestone Pharmaceuticals report Q1 2025 earnings?
- Milestone Pharmaceuticals (MIST) reported Q1 2025 earnings on May 14, 2025 before market open.
- What were Milestone Pharmaceuticals's Q1 2025 revenue and EPS?
- Milestone Pharmaceuticals reported diluted EPS of $-0.31 for Q1 2025.
- Did Milestone Pharmaceuticals beat estimates in Q1 2025?
- EPS missed the consensus estimate of $-0.19 by $0.12.
- How did Milestone Pharmaceuticals's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS declined 47.6% from $-0.21.
- Where can I find Milestone Pharmaceuticals's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001558370-25-007648) directly on SEC EDGAR. The filing index links above go to sec.gov.